About Us
We focus on advancing the evidence-based and responsible integration of Personalized Medicine into healthcare systems
Our work addresses the growing gap between rapid innovation in omics technologies and their limited implementation in routine clinical practice.
Personalized Medicine relies on the use of genomic, transcriptomic, proteomic, and multi-omics data to support patient stratification, biomarker discovery, and targeted therapeutic strategies.
While these technologies generate unprecedented molecular insights, their clinical value depends on analytical validity, clinical validity, and demonstrated clinical utility.
Generating data alone is not sufficient; meaningful impact requires:
Structured evaluation
System-level integration
Alignment with healthcare needs
Our mission is to analyze and clarify the scientific, clinical, economic, regulatory, and ethical factors that influence the adoption of omics-based innovations.
We emphasize:
Health Technology Assessment (HTA) and adaptive evidence generation,
Economic evaluation and cost-effectiveness in budget-constrained healthcare systems,
Bioinformatics and data interpretation, transforming complex molecular data into clinically actionable information,
Clinical workflow integration and decision-support systems
Data governance, interoperability, and privacy frameworks
Equity, transparency, and patient engagement as core societal values.
We adopt a system-level perspective, recognizing that sustainable implementation of Personalized Medicine requires coordination across laboratories, clinical practice, digital infrastructures, regulatory frameworks, and policy environments. Technologies that fail to demonstrate long-term clinical and economic value risk remaining confined to research settings.
By promoting rigorous evaluation, real-world evidence generation, and integrated data approaches, we aim to support a healthcare model where innovation translates into measurable patient benefit, efficient resource use, and long-term system sustainability.